6.7(top 5%)
impact factor
1.1K(top 20%)
papers
28.6K(top 10%)
citations
75(top 10%)
h-index
6.9(top 5%)
impact factor
1.3K
all documents
31.8K
doc citations
110(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsyNeurology: Neuroimmunology and NeuroInflammation2017334
2MOG cell-based assay detects non-MS patients with inflammatory neurologic diseaseNeurology: Neuroimmunology and NeuroInflammation2015322
3Updated Diagnostic Criteria for Paraneoplastic Neurologic SyndromesNeurology: Neuroimmunology and NeuroInflammation2021313
4Guillain-Barré syndrome related to COVID-19 infectionNeurology: Neuroimmunology and NeuroInflammation2020288
5Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?Neurology: Neuroimmunology and NeuroInflammation2015242
6Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in childrenNeurology: Neuroimmunology and NeuroInflammation2015205
7Rituximab in treatment-resistant CIDP with antibodies against paranodal proteinsNeurology: Neuroimmunology and NeuroInflammation2015205
8Antibodies to MOG in adults with inflammatory demyelinating disease of the CNSNeurology: Neuroimmunology and NeuroInflammation2015203
9Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic diseaseNeurology: Neuroimmunology and NeuroInflammation2020201
10Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritisNeurology: Neuroimmunology and NeuroInflammation2014192
11International multicenter examination of MOG antibody assaysNeurology: Neuroimmunology and NeuroInflammation2020180
12Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosisNeurology: Neuroimmunology and NeuroInflammation2016178
13Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patientNeurology: Neuroimmunology and NeuroInflammation2020178
14Early CNS neurodegeneration in radiologically isolated syndromeNeurology: Neuroimmunology and NeuroInflammation2015177
15Aquaporin-4 autoimmunityNeurology: Neuroimmunology and NeuroInflammation2015173
16Apheresis therapies for NMOSD attacksNeurology: Neuroimmunology and NeuroInflammation2018173
17IgLON5 antibodyNeurology: Neuroimmunology and NeuroInflammation2017172
18Reduction of CD8 + T lymphocytes in multiple sclerosis patients treated with dimethyl fumarateNeurology: Neuroimmunology and NeuroInflammation2015171
19COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemiaNeurology: Neuroimmunology and NeuroInflammation2020165
20Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizuresNeurology: Neuroimmunology and NeuroInflammation2015163
21Acute disseminated encephalomyelitis after SARS-CoV-2 infectionNeurology: Neuroimmunology and NeuroInflammation2020163
22Rituximab before and during pregnancyNeurology: Neuroimmunology and NeuroInflammation2018159
23Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeletonNeurology: Neuroimmunology and NeuroInflammation2014158
24Effects of neuromyelitis optica–IgG at the blood–brain barrier in vitroNeurology: Neuroimmunology and NeuroInflammation2017153
25Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitisNeurology: Neuroimmunology and NeuroInflammation2017146
26Next-generation sequencing in neuropathologic diagnosis of infections of the nervous systemNeurology: Neuroimmunology and NeuroInflammation2016142
27P2Y12 expression and function in alternatively activated human microgliaNeurology: Neuroimmunology and NeuroInflammation2015139
28Neuroleptic intolerance in patients with anti-NMDAR encephalitisNeurology: Neuroimmunology and NeuroInflammation2016139
29Neuromyelitis optica spectrum disordersNeurology: Neuroimmunology and NeuroInflammation2016134
30Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?Neurology: Neuroimmunology and NeuroInflammation2019133
31B lymphocytes in neuromyelitis opticaNeurology: Neuroimmunology and NeuroInflammation2015132
32COVID-19 outcomes in MSNeurology: Neuroimmunology and NeuroInflammation2020130
33Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosisNeurology: Neuroimmunology and NeuroInflammation2016129
34Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitorsNeurology: Neuroimmunology and NeuroInflammation2019129
35Microstructural visual system changes in AQP4-antibody–seropositive NMOSDNeurology: Neuroimmunology and NeuroInflammation2017128
36Both cladribine and alemtuzumab may effect MS via B-cell depletionNeurology: Neuroimmunology and NeuroInflammation2017121
37Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MSNeurology: Neuroimmunology and NeuroInflammation2016118
38The topographical model of multiple sclerosisNeurology: Neuroimmunology and NeuroInflammation2016118
39Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDPNeurology: Neuroimmunology and NeuroInflammation2020118
40Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosisNeurology: Neuroimmunology and NeuroInflammation2016117
41Expanded autologous regulatory T-lymphocyte infusions in ALSNeurology: Neuroimmunology and NeuroInflammation2018116
42Clinical utility of testing AQP4-IgG in CSFNeurology: Neuroimmunology and NeuroInflammation2016113
43Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiologyNeurology: Neuroimmunology and NeuroInflammation2020112
44Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033Neurology: Neuroimmunology and NeuroInflammation2014111
45Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcomeNeurology: Neuroimmunology and NeuroInflammation2020110
46Neurologic syndromes related to anti-GAD65Neurology: Neuroimmunology and NeuroInflammation2020110
47No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribineNeurology: Neuroimmunology and NeuroInflammation2015109
48Neurofilament light chain predicts disease activity in relapsing-remitting MSNeurology: Neuroimmunology and NeuroInflammation2018107
49COVID-19-associated acute necrotizing myelitisNeurology: Neuroimmunology and NeuroInflammation2020107
50Anti-NMDAR encephalitisNeurology: Neuroimmunology and NeuroInflammation2020106